申请人:UNIVERSITE DE LILLE 2 DROIT ET SANTE
公开号:US10323016B2
公开(公告)日:2019-06-18
The present invention is directed to novel compounds of formula (I), pharmaceutically acceptable salts or solvates thereof, and their use.
本发明涉及新型式 (I) 化合物、其药学上可接受的盐或溶液及其用途。